RNA-based biomarker signatures in plasma as an independent predictor of outcome to chemotherapy in lung, colon, and breast cancers: Correlation of relative PD-L1 expression with immunotherapy outcomes.

Luis E. Raez,J Usher,Kathleen D. Danenberg,D. Sumarriva,Aurelio Castrellon,Shahrooz Rabizadeh,Adriana Milillo,Brian Hunis,Sandip Reddy,Liyang Huang,Jennifer Zikria,Pablo Ferraro,Peter V. Danenberg

RNA-based biomarker signatures in plasma as an independent predictor of outcome to chemotherapy in lung, colon, and breast cancers: Correlation of relative PD-L1 expression with immunotherapy outcomes.

2019

Luis E. Raez
J Usher
Kathleen D. Danenberg
D. Sumarriva
Aurelio Castrellon
Shahrooz Rabizadeh
Adriana Milillo
Brian Hunis
Sandip Reddy
Liyang Huang
Jennifer Zikria
Pablo Ferraro
Peter V. Danenberg

e14567Background: Levels of cell-free circulating RNA (cfRNA) in cancer patients (pts) indicate tumor gene expressions and thus may provide a means, not only of evaluating response, but also for mo...

Keywords:

PD-L1
RNA
Immunotherapy
Correlation
Pathology
Biomarker (medicine)
Oncology
Lung
Chemotherapy
Medicine
Internal medicine
Gene
Cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations